A Pilot, Open-Label, Multi-Center, Multi-Dose Study of GRN-1201 Added to Pembrolizumab in Subjects with Non-Small Cell Lung Cancer with High PD-L1 Expression
This study is currently enrolling.
The study drug is known as GRN-1201 and is a type of cancer vaccine made up of four peptides (short chains of amino acids) that can cause an immune system response against cancer cells. Amino acids are what make up proteins. T ...